TG Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for TG Therapeutics, Inc. (TGTX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income23.3812.67-198.34-348.10-279.38-172.87-173.48
Depreciation & Amortization0.280.420.522.091.270.800.22
Stock Based Compensation42.5437.9344.6661.2780.290.000.00
Change in Working Capital-109.30-84.66-1.65-12.22-19.7625.1927.63
Change in Accounts Receivable-78.09-51.091.39-1.390.000.000.00
Change in Inventory-66.85-36.940.000.000.000.000.00
Change in Accounts Payable0.000.19-11.0115.9911.630.000.00
Change in Other Working Capital4.204.454.442.40-31.240.000.00
Other Operating Activities4.204.454.4460.7081.0411.563.94
Net Cash from Operating Activities-40.52-31.41-176.17-295.63-214.51-132.81-128.93
Investing Activities
Capital Expenditures-0.050.00-0.010.400.360.13-0.09
Purchases of Investments-311.89-146.88-107.27-55.53-24.150.000.00
Sales/Maturities of Investments310.9096.2387.281.97-21.831.931.27
Other Investing Activities0.000.00-17.281.97-21.831.930.00
Net Cash from Investing Activities-1.04-50.65-20.01-0.33-24.51-0.721.18
Financing Activities
Debt Repayment-107.550.00-0.98-30.000.000.000.00
Common Stock Issued0.0046.300.582.22679.830.00113.64
Common Stock Repurchased-8.760.000.000.000.000.000.00
Other Financing Activities-0.89-0.130.001.20679.68175.020.00
Net Cash from Financing Activities128.5372.71-0.3941.42679.83204.21113.64
Summary
Net Change in Cash86.97-9.36-196.57-254.55440.8170.69-14.11
Cash at Beginning of Period94.22103.58300.15554.70113.8943.2057.31
Cash at End of Period181.1994.22103.58300.15554.70113.8943.20
Free Cash Flow-40.56-31.41-176.18-296.04-214.86-132.94-129.02
Supplemental Disclosures
Interest Paid18.478.775.453.474.500.000.00
Income Taxes Paid0.500.000.000.000.000.000.00